Volume : 10, Issue : 02, February – 2023
Title:
15.FORMULATION AND EVALUATION OF SIMVASTATIN MATRIX TABLETS
Authors :
Meedidoddi Priyanka, D.Rajkumar
Abstract :
The Purpose of this Research work was to Formulate and Evaluate Anti-Hyperlipidemic Drug (HMG-coA reductase Inhibitor) in a Controlled discharge dose type of Simvastatin Matrix Tablets.The Tablets were Prepared by utilizing HMPC K15M, HMPC K100M, MicroCrystalline Cellulose , sodium CMC, Magnesium Streate and concentrated with various rate Controlling polymers. The Technique Employed is the Preparation of Matrix Tablet framework by direct Compression Matrix.The Sustainability of the medication is safe,Effective and stable Controlled Release Dosage type of HMPC K100M at centralization of 40mg in blend with Ethyl Cellulose at20mg was seen as acceptable Sustainability and 99% medication discharge in 24 hrs. The enhanced Formulation was assessed with Parameters like Thickness, friability , weight Variation, medicate Content, Invitro Drug discharge and Results were seen as inside the Limits.
Keywords: Matrix tablets, HMPC K15M, HMPC K100M, MicroCrystalline Cellulose, Controlled discharge, Simvastatin
Cite This Article:
Please cite this article in press Meedidoddi Priyanka et al, Formulation And Evaluation Of Simvastatin Matrix Tablets., Indo Am. J. P. Sci, 2023; 10 (02).
Number of Downloads : 10
References:
2. Vyas SP, Khar R K: Controlled Drug Delivery: Concepts and Advances. Vallabh Prakashan Publishers Delhi, 3rd edition. 2002.
3. Pandit JK, Singh S and Muthu MS. Controlled release formulation in neurology practice. Annual of Ind Acadamy of Neurolgy 2006; 207 – 216.
4. Colombo P, Bettini R and Peppas NA. Observation of swelling process and diffusion front position during swelling in Hydroxy propyl methyl cellulose (HPMC) matrices containing a soluble drug. Journal of Controlled Release 1999; 61: 83 –91.
5. Manthena VS Varma, Aditya M. Kaushal, Alka Garg and Sanjay Garg. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. American Journal of Drug Delivery 2004; 2:43-57.
6. Indian Pharmacopoeia (IP), Vol. I Published by the controller of Publications, Delhi, 1996.
7. The Merck Index, Published by Merck Research Laboratories, Division of Merck and Co. INC., Whitehouse Station, NJ Thirteen Edition 2001.
8. Reynold J and F. Efition, Martindale. The extrapharmacopoeia, XXXIII, London Pharmaceutical Press, 1993.
9. Hogland P and Wilson LG. Pharmacokinetics of diltiazem and its metabolite after repeated multiple dose treatment in healthy volunteers. The Drug Monitoring. 1989; 11: 543- 50.